FindTrial
Sign In

the development of patient-reported-outcome scale based on sf-36 about plasma cell mastitis

the development of patient-reported-outcome scale based on sf-36 about plasma cell mastitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042193
Enrollment
Unknown
Registered
2021-01-15
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plasma cell mastitis

Interventions

case series:Nil

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women who accept treatment in hospital whose pathologic diagnosis are plasma cell mastitis. 2. Women who are diagnosed as plasma cell mastitis based on radiologic findings and experience by doctors of mammary gland.

Exclusion criteria

Exclusion criteria: 1. Breast cancer,FA or other diseases of mammary gland; 2. complicated with heart, brain, kidney, hematopoietic system and other serious diseases; 3. complicated with tumor; 4. patients who have not completed treatment and transferred to other hospitals or discharged automatically; 5. patients with incomplete information; 6. patients who can not follow up.

Design outcomes

Primary

MeasureTime frame
scale;—

Countries

China

Contacts

Public ContactZiaoyi Zhao

Longhua Hospital Shanghai University of Traditional Chinese Medicine

425360982@qq.com+86 13162896177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026